Toei Shinyaku’s Patents for β-Glucan Detection Technology Featured in Two Japanese Trade Newspapers

Toei Shinyaku’s patents for β-glucan detection and quantification technology were featured in two Japanese industry newspapers in November 2026: Shokuhin Kagaku Shimbun (Food Chemical News, November 5, 2026 issue) and Nihon Ryutsu Sangyo Shimbun (Japan Distribution Industry Newspaper, November 12, 2026 issue).

What the articles covered

  • The technology detects and quantifies β-1,6-branched β-1,3-glucan and β-1,3-glucan. It uses a split reporter protein: fusion proteins bind to the target β-glucan and reconstitute an active reporter, and its activity indicates how much β-glucan is present.
  • It was developed through joint research with the Laboratory for Immunopharmacology of Microbial Products, Tokyo University of Pharmacy and Life Sciences.
  • The patent is now in force in three countries: Japan (registered February 2025), the United States (September 2026, U.S. Patent No. US12736534B2) and China (effective October 9, 2026, Patent No. ZL202180032661.0).
  • The research grew out of our work on King Agaricus KA21, cultivated outdoors in Brazil, whose β-glucan contains multiple β-1,6 and β-1,3 linkages.
  • Possible applications include measuring the β-glucan content of King Agaricus KA21 products, research into how β-glucan works, and diagnosis of fungal infections.

We will continue to build scientific evidence on King Agaricus KA21 together with our research partners.

Original articles (Japanese, PDF)

Related information